Homo sapiens |
Histone deacetylase 6 |
Inhibition |
-27.15 |
% |
10.6019/CHEMBL4808148 |
Homo sapiens |
Histone deacetylase 6 |
Inhibition |
-4.98 |
% |
10.6019/CHEMBL4808148 |
Alternaria solani |
Alternaria solani |
Activity |
68.4 |
% |
10.1016/j.ejmech.2021.114057 |
Bipolaris maydis |
Bipolaris maydis |
Activity |
36.4 |
% |
10.1016/j.ejmech.2021.114057 |
Homo sapiens |
Indoleamine 2,3-dioxygenase |
Inhibition |
34.0 |
% |
10.1021/acs.jmedchem.2c00677 |
Homo sapiens |
Tryptophan 2,3-dioxygenase |
Inhibition |
85.0 |
% |
10.1021/acs.jmedchem.2c00677 |
Homo sapiens |
Tryptophan 2,3-dioxygenase |
IC50 |
6310.0 |
nM |
10.1021/acs.jmedchem.2c00677 |
Rattus norvegicus |
GABA-A receptor; anion channel |
IC50 |
12387.97 |
nM |
10.1021/jm950589q |
Rattus norvegicus |
GABA-A receptor; anion channel |
Ki |
12400.0 |
nM |
10.1021/jm00351a015 |
Rattus norvegicus |
GABA-A receptor; anion channel |
IC50 |
12387.97 |
nM |
10.1021/jm00072a012 |
Homo sapiens |
GABA-A receptor; anion channel |
IC50 |
12302.69 |
nM |
10.1021/jm970488n |
Rattus norvegicus |
GABA-A receptor; anion channel |
IC50 |
12400.0 |
nM |
10.1021/jm00171a007 |
None |
Unchecked |
Activity |
27.0 |
pg/microg/hr |
10.1016/j.bmc.2007.05.075 |
None |
Unchecked |
Activity |
20.0 |
pg/microg/hr |
10.1016/j.bmc.2007.05.075 |
None |
Unchecked |
Activity |
37.0 |
pg/microg/hr |
10.1016/j.bmc.2007.05.075 |
None |
Unchecked |
Ki |
36.0 |
nM |
10.1016/j.bmc.2007.05.075 |
None |
Unchecked |
Ki |
54.0 |
nM |
10.1016/j.bmc.2007.05.075 |
None |
Unchecked |
Ki |
12000.0 |
nM |
10.1016/j.bmc.2007.05.075 |
None |
Unchecked |
IC50 |
12302.69 |
nM |
10.1016/j.ejmech.2007.09.004 |
Homo sapiens |
HepG2 |
IC50 |
115000.0 |
nM |
10.1016/j.bmcl.2008.10.043 |
Homo sapiens |
Bel-7402 |
IC50 |
151000.0 |
nM |
10.1016/j.bmcl.2008.10.043 |
Homo sapiens |
HeLa |
IC50 |
186000.0 |
nM |
10.1016/j.bmcl.2008.10.043 |
Homo sapiens |
BGC-823 |
IC50 |
215000.0 |
nM |
10.1016/j.bmcl.2008.10.043 |
None |
Unchecked |
IC50 |
12302.69 |
nM |
10.1016/j.ejmech.2008.01.030 |
Homo sapiens |
Serine/threonine-protein kinase PAK7 |
Activity |
97.0 |
% |
10.1042/bj20070797 |
Homo sapiens |
Serine/threonine-protein kinase PAK6 |
Activity |
105.0 |
% |
10.1042/bj20070797 |
Homo sapiens |
3-phosphoinositide dependent protein kinase-1 |
Activity |
90.0 |
% |
10.1042/bj20070797 |
None |
Unchecked |
Activity |
102.0 |
% |
10.1042/bj20070797 |
Homo sapiens |
Serine/threonine-protein kinase PIM1 |
Activity |
94.0 |
% |
10.1042/bj20070797 |
Homo sapiens |
Serine/threonine-protein kinase PIM2 |
Activity |
85.0 |
% |
10.1042/bj20070797 |
Homo sapiens |
Serine/threonine-protein kinase PIM3 |
Activity |
80.0 |
% |
10.1042/bj20070797 |
Homo sapiens |
cAMP-dependent protein kinase alpha-catalytic subunit |
Activity |
95.0 |
% |
10.1042/bj20070797 |
Homo sapiens |
Serine/threonine-protein kinase AKT |
Activity |
104.0 |
% |
10.1042/bj20070797 |
Homo sapiens |
Serine/threonine-protein kinase AKT2 |
Activity |
91.0 |
% |
10.1042/bj20070797 |
Homo sapiens |
Protein kinase C alpha |
Activity |
90.0 |
% |
10.1042/bj20070797 |
Homo sapiens |
Protein kinase C zeta |
Activity |
89.0 |
% |
10.1042/bj20070797 |
Homo sapiens |
Serine/threonine-protein kinase SRPK1 |
Activity |
81.0 |
% |
10.1042/bj20070797 |
Homo sapiens |
Serine/threonine-protein kinase Chk2 |
Activity |
92.0 |
% |
10.1042/bj20070797 |
Homo sapiens |
Casein kinase I delta |
Activity |
99.0 |
% |
10.1042/bj20070797 |
Homo sapiens |
Casein kinase II |
Activity |
85.0 |
% |
10.1042/bj20070797 |
Homo sapiens |
Tyrosine-protein kinase CSK |
Activity |
81.0 |
% |
10.1042/bj20070797 |
Homo sapiens |
Dual-specificity tyrosine-phosphorylation regulated kinase 1A |
Activity |
44.0 |
% |
10.1042/bj20070797 |
Homo sapiens |
Dual-specificity tyrosine-phosphorylation regulated kinase 2 |
Activity |
83.0 |
% |
10.1042/bj20070797 |
Homo sapiens |
Dual-specificity tyrosine-phosphorylation regulated kinase 3 |
Activity |
72.0 |
% |
10.1042/bj20070797 |
Homo sapiens |
Serine/threonine-protein kinase c-TAK1 |
Activity |
128.0 |
% |
10.1042/bj20070797 |
Homo sapiens |
Maternal embryonic leucine zipper kinase |
Activity |
82.0 |
% |
10.1042/bj20070797 |
Homo sapiens |
Dual specificity mitogen-activated protein kinase kinase 1 |
Activity |
90.0 |
% |
10.1042/bj20070797 |
Homo sapiens |
MAP kinase-interacting serine/threonine-protein kinase MNK1 |
Activity |
82.0 |
% |
10.1042/bj20070797 |
Homo sapiens |
MAP kinase signal-integrating kinase 2 |
Activity |
112.0 |
% |
10.1042/bj20070797 |
Homo sapiens |
Ribosomal protein S6 kinase alpha 5 |
Activity |
91.0 |
% |
10.1042/bj20070797 |
Homo sapiens |
Protein kinase C mu |
Activity |
88.0 |
% |
10.1042/bj20070797 |
Homo sapiens |
Serine/threonine-protein kinase PLK1 |
Activity |
81.0 |
% |
10.1042/bj20070797 |
Homo sapiens |
MAP kinase-activated protein kinase 5 |
Activity |
84.0 |
% |
10.1042/bj20070797 |
Homo sapiens |
Protein kinase N2 |
Activity |
85.0 |
% |
10.1042/bj20070797 |
Homo sapiens |
THP-1 |
IC50 |
121000.0 |
nM |
10.1016/j.bmc.2009.08.057 |
Plasmodium falciparum |
Plasmodium falciparum |
IC50 |
7100.0 |
nM |
10.1016/j.bmc.2009.08.057 |
Plasmodium falciparum |
Plasmodium falciparum |
IC50 |
12100.0 |
nM |
10.1016/j.bmc.2009.08.057 |
Plasmodium falciparum |
Plasmodium falciparum |
IC50 |
12589.25 |
nM |
10.1038/nchembio.215 |
Plasmodium falciparum |
Plasmodium falciparum |
IC50 |
12589.25 |
nM |
10.1038/nchembio.215 |
None |
Unchecked |
Inhibition |
nan |
% |
10.1038/nchembio873 |
Homo sapiens |
Menin/Histone-lysine N-methyltransferase MLL |
Potency |
39810.7 |
nM |
None |
None |
Unchecked |
Potency |
10000.0 |
nM |
None |
Trypanosoma cruzi |
Cruzipain |
Potency |
25118.9 |
nM |
None |
Trypanosoma cruzi |
Cruzipain |
Potency |
39810.7 |
nM |
None |
Homo sapiens |
Nuclear factor NF-kappa-B p105 subunit |
Potency |
1995.3 |
nM |
None |
Homo sapiens |
Thyroid stimulating hormone receptor |
Potency |
25118.9 |
nM |
None |
Bacillus anthracis |
Anthrax lethal factor |
Potency |
1995.3 |
nM |
None |
Homo sapiens |
15-hydroxyprostaglandin dehydrogenase [NAD+] |
Potency |
12589.3 |
nM |
None |
Homo sapiens |
15-hydroxyprostaglandin dehydrogenase [NAD+] |
Potency |
22387.2 |
nM |
None |
Homo sapiens |
Endoplasmic reticulum-associated amyloid beta-peptide-binding protein |
Potency |
25118.9 |
nM |
None |
None |
Unchecked |
Potency |
1000.0 |
nM |
None |
None |
Unchecked |
Potency |
3162.3 |
nM |
None |
None |
NON-PROTEIN TARGET |
EC50 |
14400.0 |
nM |
10.1128/aac.01614-08 |
None |
ADMET |
Ratio |
2.0 |
None |
10.1128/aac.01614-08 |
None |
ADMET |
TC50 |
40.0 |
uM |
10.1128/aac.01614-08 |
Rattus norvegicus |
Thioredoxin reductase 1, cytoplasmic |
Potency |
21192.3 |
nM |
None |
None |
Unchecked |
Potency |
16360.1 |
nM |
None |
Homo sapiens |
Arachidonate 15-lipoxygenase, type II |
Potency |
15848.9 |
nM |
None |
Homo sapiens |
Cytochrome P450 2D6 |
AC50 |
10000.0 |
nM |
None |
Homo sapiens |
Cytochrome P450 2C19 |
AC50 |
nan |
None |
None |
Rattus norvegicus |
Thioredoxin reductase 1, cytoplasmic |
Potency |
22387.2 |
nM |
None |
Rattus norvegicus |
Thioredoxin reductase 1, cytoplasmic |
Potency |
56234.1 |
nM |
None |
Rattus norvegicus |
Thioredoxin reductase 1, cytoplasmic |
Potency |
100000.0 |
nM |
None |
None |
Unchecked |
Potency |
31622.8 |
nM |
None |
Homo sapiens |
DNA-(apurinic or apyrimidinic site) lyase |
Potency |
31622.8 |
nM |
None |
Homo sapiens |
DNA-(apurinic or apyrimidinic site) lyase |
Potency |
39810.7 |
nM |
None |
None |
Unchecked |
Potency |
15848.9 |
nM |
None |
Leishmania infantum |
Leishmania infantum |
IC50 |
270.0 |
nM |
10.1016/j.bmcl.2014.06.030 |
Leishmania infantum |
Leishmania infantum |
IC50 |
19200.0 |
nM |
10.1016/j.bmcl.2014.06.030 |
Leishmania donovani |
Leishmania donovani |
IC50 |
19200.0 |
nM |
10.1016/j.bmcl.2014.06.030 |
Leishmania donovani |
Leishmania donovani |
IC50 |
270.0 |
nM |
10.1016/j.bmcl.2014.06.030 |
Homo sapiens |
HEK-293T |
Activity |
nan |
None |
10.1021/ml500516r |
Onchocerca volvulus |
Chitinase |
IC50 |
7330.0 |
nM |
10.1021/ml500516r |
Onchocerca volvulus |
Onchocerca volvulus |
Inhibition |
nan |
% |
10.1021/ml500516r |
Onchocerca volvulus |
Onchocerca volvulus |
Activity |
nan |
None |
10.1021/ml500516r |
Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
Inhibition |
-0.85 |
% |
10.21203/rs.3.rs-23951/v1 |
Leishmania infantum |
Leishmania infantum |
IC50 |
19200.0 |
nM |
10.1016/j.ejmech.2016.08.014 |
Homo sapiens |
KB |
ED50 |
8.9 |
ug ml-1 |
10.1016/s0960-894x(99)00598-3 |
Homo sapiens |
A549 |
ED50 |
9.3 |
ug ml-1 |
10.1016/s0960-894x(99)00598-3 |
Homo sapiens |
CAKI-1 |
ED50 |
8.0 |
ug ml-1 |
10.1016/s0960-894x(99)00598-3 |
Homo sapiens |
MCF7 |
ED50 |
19.0 |
ug ml-1 |
10.1016/s0960-894x(99)00598-3 |
Homo sapiens |
1A9 |
ED50 |
6.1 |
ug ml-1 |
10.1016/s0960-894x(99)00598-3 |
Homo sapiens |
SK-MEL-2 |
ED50 |
20.0 |
ug ml-1 |
10.1016/s0960-894x(99)00598-3 |
Homo sapiens |
U-87 MG |
ED50 |
19.0 |
ug ml-1 |
10.1016/s0960-894x(99)00598-3 |
Homo sapiens |
HEL |
ED50 |
9.8 |
ug ml-1 |
10.1016/s0960-894x(99)00598-3 |
Homo sapiens |
KB |
ED50 |
16.5 |
ug ml-1 |
10.1016/s0960-894x(99)00598-3 |
Homo sapiens |
KB |
ED50 |
17.5 |
ug ml-1 |
10.1016/s0960-894x(99)00598-3 |
Homo sapiens |
KB |
ED50 |
15.0 |
ug ml-1 |
10.1016/s0960-894x(99)00598-3 |
Homo sapiens |
H9 |
IC50 |
111500.0 |
nM |
10.1021/np0101189 |
Human immunodeficiency virus 1 |
Human immunodeficiency virus 1 |
EC50 |
10700.0 |
nM |
10.1021/np0101189 |
None |
ADMET |
Ratio IC50/EC50 |
10.4 |
None |
10.1021/np0101189 |
Trichophyton mentagrophytes |
Trichophyton mentagrophytes |
MID |
3.7 |
ug ml-1 |
10.1021/np8007655 |
Candida albicans |
Candida albicans |
MID |
1.9 |
ug ml-1 |
10.1021/np8007655 |
Bacillus subtilis |
Bacillus subtilis |
MID |
7.5 |
ug ml-1 |
10.1021/np8007655 |
Mus musculus |
P388 |
IC50 |
12.5 |
ug.mL-1 |
10.1021/np8007655 |
Homo sapiens |
Ribosomal protein S6 kinase alpha 1 |
Activity |
98.0 |
% |
10.1042/bj20070797 |
Homo sapiens |
Ribosomal protein S6 kinase alpha 3 |
Activity |
94.0 |
% |
10.1042/bj20070797 |
Homo sapiens |
Ribosomal protein S6 kinase 1 |
Activity |
94.0 |
% |
10.1042/bj20070797 |
Homo sapiens |
Serine/threonine-protein kinase Sgk1 |
Activity |
86.0 |
% |
10.1042/bj20070797 |
Homo sapiens |
Myosin light chain kinase, smooth muscle |
Activity |
100.0 |
% |
10.1042/bj20070797 |
Gallus gallus |
Tyrosine-protein kinase SRC |
Activity |
83.0 |
% |
10.1042/bj20070797 |
Homo sapiens |
Serine/threonine-protein kinase EEF2K |
Activity |
101.0 |
% |
10.1042/bj20070797 |
Homo sapiens |
MAP kinase ERK1 |
Activity |
107.0 |
% |
10.1042/bj20070797 |
Homo sapiens |
MAP kinase ERK2 |
Activity |
95.0 |
% |
10.1042/bj20070797 |
Homo sapiens |
Mitogen-activated protein kinase 15 |
Activity |
70.0 |
% |
10.1042/bj20070797 |
Homo sapiens |
Serine/threonine-protein kinase MST2 |
Activity |
81.0 |
% |
10.1042/bj20070797 |
Homo sapiens |
Serine/threonine-protein kinase NEK2 |
Activity |
79.0 |
% |
10.1042/bj20070797 |
Homo sapiens |
Serine/threonine-protein kinase NEK6 |
Activity |
90.0 |
% |
10.1042/bj20070797 |
Homo sapiens |
Serine/threonine-protein kinase NEK7 |
Activity |
105.0 |
% |
10.1042/bj20070797 |
Homo sapiens |
MAP kinase p38 alpha |
Activity |
74.0 |
% |
10.1042/bj20070797 |
None |
NON-PROTEIN TARGET |
IC50 |
130000.0 |
nM |
10.1021/jm901816j |
Homo sapiens |
Lysine-specific demethylase 4D-like |
Potency |
31622.8 |
nM |
None |
Homo sapiens |
Lysine-specific demethylase 4D-like |
Potency |
31622.8 |
nM |
None |
Homo sapiens |
Lysine-specific demethylase 4D-like |
Potency |
7943.3 |
nM |
None |
Homo sapiens |
Lysine-specific demethylase 4D-like |
Potency |
22387.2 |
nM |
None |
Homo sapiens |
Lysine-specific demethylase 4D-like |
Potency |
28183.8 |
nM |
None |
None |
Unchecked |
Potency |
12589.3 |
nM |
None |
None |
NON-PROTEIN TARGET |
Potency |
10000.0 |
nM |
None |
Trypanosoma cruzi |
Cruzipain |
Potency |
25118.9 |
nM |
None |
Homo sapiens |
Aldehyde dehydrogenase 1A1 |
Potency |
31622.8 |
nM |
None |
Homo sapiens |
Aldehyde dehydrogenase 1A1 |
Potency |
25118.9 |
nM |
None |
Homo sapiens |
Aldehyde dehydrogenase 1A1 |
Potency |
11220.2 |
nM |
None |
Homo sapiens |
Aldehyde dehydrogenase 1A1 |
Potency |
28183.8 |
nM |
None |
Homo sapiens |
Aldehyde dehydrogenase 1A1 |
Potency |
31622.8 |
nM |
None |
None |
NON-PROTEIN TARGET |
Potency |
12589.3 |
nM |
None |
Homo sapiens |
Microtubule-associated protein tau |
Potency |
562.3 |
nM |
None |
None |
NON-PROTEIN TARGET |
Potency |
14125.4 |
nM |
None |
None |
NON-PROTEIN TARGET |
Potency |
15848.9 |
nM |
None |
Homo sapiens |
MAP kinase ERK2 |
Potency |
100000.0 |
nM |
None |
Trypanosoma cruzi |
Cruzipain |
Potency |
39810.7 |
nM |
None |
Homo sapiens |
Bloom syndrome protein |
Potency |
19952.6 |
nM |
None |
Homo sapiens |
15-hydroxyprostaglandin dehydrogenase [NAD+] |
Potency |
31622.8 |
nM |
None |
Homo sapiens |
15-hydroxyprostaglandin dehydrogenase [NAD+] |
Potency |
35481.3 |
nM |
None |
Homo sapiens |
15-hydroxyprostaglandin dehydrogenase [NAD+] |
Potency |
28183.8 |
nM |
None |
Rattus norvegicus |
Muscarinic acetylcholine receptor M1 |
Potency |
25118.9 |
nM |
None |
Homo sapiens |
Cytochrome P450 2D6 |
Potency |
10000.0 |
nM |
None |
None |
NON-PROTEIN TARGET |
Potency |
11220.2 |
nM |
None |
Homo sapiens |
Cytochrome P450 2D6 |
Potency |
31622.8 |
nM |
None |
Homo sapiens |
Cytochrome P450 2D6 |
Potency |
10000.0 |
nM |
None |
Homo sapiens |
Cytochrome P450 3A4 |
Potency |
3981.1 |
nM |
None |
Trypanosoma brucei |
6-phospho-1-fructokinase |
Potency |
756.9 |
nM |
None |
Homo sapiens |
Cytochrome P450 2C9 |
AC50 |
nan |
None |
None |
Homo sapiens |
Cytochrome P450 2C9 |
AC50 |
nan |
None |
None |
Homo sapiens |
Cytochrome P450 3A4 |
AC50 |
nan |
None |
None |
Homo sapiens |
Cytochrome P450 2D6 |
AC50 |
10000.0 |
nM |
None |
Homo sapiens |
Cytochrome P450 2C19 |
AC50 |
nan |
None |
None |
Homo sapiens |
Regulator of G-protein signaling 4 |
Potency |
15003.0 |
nM |
None |
None |
Unchecked |
Potency |
19952.6 |
nM |
None |
None |
NON-PROTEIN TARGET |
IC50 |
130000.0 |
nM |
10.1016/j.ejmech.2011.09.027 |
Electrophorus electricus |
Acetylcholinesterase |
IC50 |
20910.0 |
nM |
10.1016/j.bmcl.2012.02.057 |
Electrophorus electricus |
Acetylcholinesterase |
Inhibition |
83.19 |
% |
10.1016/j.bmcl.2012.02.057 |
Homo sapiens |
Acetylcholinesterase |
IC50 |
nan |
None |
10.1016/j.bmcl.2012.02.057 |
Homo sapiens |
Acetylcholinesterase |
Inhibition |
43.54 |
% |
10.1016/j.bmcl.2012.02.057 |
Homo sapiens |
DNA repair and recombination protein RAD54-like |
AC50 |
58370.0 |
nM |
None |
None |
Unchecked |
IC50 |
12302.69 |
nM |
10.1007/s00044-008-9111-6 |
Homo sapiens |
Tyrosyl-DNA phosphodiesterase 1 |
Potency |
23715.0 |
nM |
None |
Homo sapiens |
Tyrosyl-DNA phosphodiesterase 1 |
Potency |
20596.2 |
nM |
None |
Homo sapiens |
Solute carrier organic anion transporter family member 1B1 |
Inhibition |
81.51 |
% |
10.1124/mol.112.084152 |
Severe acute respiratory syndrome coronavirus 2 |
Replicase polyprotein 1ab |
Inhibition |
71.52 |
% |
10.6019/CHEMBL4495564 |
Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
Inhibition |
0.5 |
% |
10.6019/CHEMBL4495565 |
Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
IC50 |
20000.0 |
nM |
10.6019/CHEMBL4651402 |
Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
IC50 |
19952.62 |
nM |
10.6019/CHEMBL4651402 |
Trichophyton interdigitale |
Trichophyton interdigitale |
MIC |
200.0 |
ug.mL-1 |
10.1016/j.ejmech.2021.114057 |
Candida albicans |
Candida albicans |
MIC |
583000.0 |
ug.mL-1 |
10.1016/j.ejmech.2021.114057 |
Homo sapiens |
DNA topoisomerase I |
ED50 |
23.8 |
ug ml-1 |
10.1016/j.ejmech.2021.113321 |
Homo sapiens |
Acetylcholinesterase |
IC50 |
10000.0 |
nM |
10.1021/acs.jmedchem.0c01887 |
Homo sapiens |
Butyrylcholinesterase |
IC50 |
10000.0 |
nM |
10.1021/acs.jmedchem.0c01887 |
Homo sapiens |
Dual-specificity tyrosine-phosphorylation regulated kinase 1A |
IC50 |
1800.0 |
nM |
10.1021/acs.jmedchem.0c01887 |
Homo sapiens |
Monoamine oxidase A |
IC50 |
29.0 |
nM |
10.1021/acs.jmedchem.0c01887 |
Homo sapiens |
GABA-A receptor; anion channel |
IC50 |
2500.0 |
nM |
10.1021/acs.jmedchem.0c01887 |
Homo sapiens |
Cytochrome P450 2D6 |
Ki |
86000.0 |
nM |
10.1021/jm00061a004 |
Homo sapiens |
Cyclin-dependent kinase 5 |
Inhibition |
65.0 |
% |
10.1016/s0960-894x(02)00094-x |
Homo sapiens |
Cyclin-dependent kinase 2 |
Inhibition |
47.0 |
% |
10.1016/s0960-894x(02)00094-x |
Escherichia coli |
Escherichia coli |
MIC |
60.0 |
ug |
10.1021/np50076a023 |
Bacillus subtilis |
Bacillus subtilis |
MIC |
7.5 |
ug |
10.1021/np50076a023 |
Pseudomonas aeruginosa |
Pseudomonas aeruginosa |
MIC |
60.0 |
ug |
10.1021/np50076a023 |
Candida albicans |
Candida albicans |
MIC |
1.9 |
ug |
10.1021/np50076a023 |
Trichophyton mentagrophytes |
Trichophyton mentagrophytes |
MIC |
3.7 |
ug |
10.1021/np50076a023 |
Amorphotheca resinae |
Amorphotheca resinae |
MIC |
15.0 |
ug |
10.1021/np50076a023 |
Mus musculus |
P388 |
IC50 |
25.0 |
ug.mL-1 |
10.1021/np50076a023 |
Human alphaherpesvirus 1 |
Human alphaherpesvirus 1 |
IZ |
nan |
None |
10.1021/np50076a023 |
Poliovirus 1 |
Poliovirus 1 |
IZ |
nan |
None |
10.1021/np50076a023 |
None |
ADMET |
IZ |
nan |
None |
10.1021/np50076a023 |
Trypanosoma cruzi |
Trypanothione reductase |
Inhibition |
10.0 |
% |
10.1016/j.bmc.2008.05.074 |
Homo sapiens |
Rho-associated protein kinase 2 |
Activity |
104.0 |
% |
10.1042/bj20070797 |
Homo sapiens |
MAP kinase p38 beta |
Activity |
90.0 |
% |
10.1042/bj20070797 |
Homo sapiens |
MAP kinase p38 delta |
Activity |
90.0 |
% |
10.1042/bj20070797 |
Homo sapiens |
MAP kinase p38 gamma |
Activity |
97.0 |
% |
10.1042/bj20070797 |
Homo sapiens |
Serine/threonine-protein kinase PAK 4 |
Activity |
103.0 |
% |
10.1042/bj20070797 |
None |
Unchecked |
Activity |
112.0 |
% |
10.1042/bj20070797 |
Homo sapiens |
Serine/threonine-protein kinase Aurora-B |
Activity |
106.0 |
% |
10.1042/bj20070797 |
Homo sapiens |
Serine/threonine-protein kinase Aurora-C |
Activity |
87.0 |
% |
10.1042/bj20070797 |
Homo sapiens |
BR serine/threonine-protein kinase 2 |
Activity |
101.0 |
% |
10.1042/bj20070797 |
Homo sapiens |
CaM kinase I alpha |
Activity |
91.0 |
% |
10.1042/bj20070797 |
Homo sapiens |
CaM-kinase kinase alpha |
Activity |
86.0 |
% |
10.1042/bj20070797 |
Homo sapiens |
CaM-kinase kinase beta |
Activity |
93.0 |
% |
10.1042/bj20070797 |
Homo sapiens |
Cyclin-dependent kinase 2/cyclin A |
Activity |
103.0 |
% |
10.1042/bj20070797 |
Homo sapiens |
Serine/threonine-protein kinase Chk1 |
Activity |
99.0 |
% |
10.1042/bj20070797 |
Homo sapiens |
Glycogen synthase kinase-3 beta |
Activity |
108.0 |
% |
10.1042/bj20070797 |
Homo sapiens |
Homeodomain-interacting protein kinase 2 |
Activity |
104.0 |
% |
10.1042/bj20070797 |
Homo sapiens |
Homeodomain-interacting protein kinase 3 |
Activity |
104.0 |
% |
10.1042/bj20070797 |
Homo sapiens |
Inhibitor of nuclear factor kappa B kinase beta subunit |
Activity |
76.0 |
% |
10.1042/bj20070797 |
Homo sapiens |
c-Jun N-terminal kinase 1 |
Activity |
92.0 |
% |
10.1042/bj20070797 |
Homo sapiens |
c-Jun N-terminal kinase 2 |
Activity |
84.0 |
% |
10.1042/bj20070797 |
Homo sapiens |
c-Jun N-terminal kinase 3 |
Activity |
89.0 |
% |
10.1042/bj20070797 |
Mus musculus |
Tyrosine-protein kinase LCK |
Activity |
93.0 |
% |
10.1042/bj20070797 |
Homo sapiens |
MAP kinase-activated protein kinase 2 |
Activity |
109.0 |
% |
10.1042/bj20070797 |
Homo sapiens |
MAP kinase-activated protein kinase 3 |
Activity |
104.0 |
% |
10.1042/bj20070797 |
Plasmodium falciparum |
Plasmodium falciparum |
IC50 |
12589.25 |
nM |
10.1038/nchembio.215 |
Plasmodium falciparum |
Plasmodium falciparum |
IC50 |
12589.25 |
nM |
10.1038/nchembio.215 |
Plasmodium falciparum |
Plasmodium falciparum |
IC50 |
12589.25 |
nM |
10.1038/nchembio.215 |
Plasmodium falciparum |
Plasmodium falciparum |
IC50 |
10000.0 |
nM |
10.1038/nchembio.215 |
Homo sapiens |
Nuclear factor NF-kappa-B p105 subunit |
Potency |
1995.3 |
nM |
None |
Homo sapiens |
Endoplasmic reticulum-associated amyloid beta-peptide-binding protein |
Potency |
25118.9 |
nM |
None |
Homo sapiens |
Endoplasmic reticulum-associated amyloid beta-peptide-binding protein |
Potency |
15848.9 |
nM |
None |
None |
NON-PROTEIN TARGET |
Potency |
11220.2 |
nM |
None |
Equus caballus |
Ferritin light chain |
Potency |
39810.7 |
nM |
None |
Homo sapiens |
Thyroid stimulating hormone receptor |
Potency |
25118.9 |
nM |
None |
Homo sapiens |
Aldehyde dehydrogenase 1A1 |
Potency |
28183.8 |
nM |
None |
Equus caballus |
Ferritin light chain |
Potency |
11220.2 |
nM |
None |
Equus caballus |
Ferritin light chain |
Potency |
19952.6 |
nM |
None |
Homo sapiens |
DNA-(apurinic or apyrimidinic site) lyase |
Potency |
35481.3 |
nM |
None |
Homo sapiens |
Endoplasmic reticulum-associated amyloid beta-peptide-binding protein |
Potency |
31622.8 |
nM |
None |
Homo sapiens |
Neuropeptide S receptor |
Potency |
5011.9 |
nM |
None |
Homo sapiens |
Cytochrome P450 3A4 |
Potency |
3981.1 |
nM |
None |
Homo sapiens |
ATPase family AAA domain-containing protein 5 |
Potency |
9196.2 |
nM |
None |
Homo sapiens |
Cytochrome P450 1A2 |
AC50 |
1258.93 |
nM |
None |
Homo sapiens |
Cytochrome P450 3A4 |
AC50 |
3981.07 |
nM |
None |
Homo sapiens |
Cytochrome P450 1A2 |
AC50 |
630.96 |
nM |
None |
Homo sapiens |
DNA polymerase iota |
Potency |
100000.0 |
nM |
None |
Homo sapiens |
HepG2 |
Potency |
2238.7 |
nM |
None |
None |
Unchecked |
Potency |
2818.4 |
nM |
None |
Rattus norvegicus |
Thioredoxin reductase 1, cytoplasmic |
Potency |
79432.8 |
nM |
None |
Rattus norvegicus |
Thioredoxin reductase 1, cytoplasmic |
Potency |
28183.8 |
nM |
None |
Rattus norvegicus |
Thioredoxin reductase 1, cytoplasmic |
Potency |
19952.6 |
nM |
None |
Homo sapiens |
Tyrosyl-DNA phosphodiesterase 1 |
Potency |
26608.6 |
nM |
None |
Homo sapiens |
Tyrosyl-DNA phosphodiesterase 1 |
Potency |
25929.0 |
nM |
None |
Homo sapiens |
Tyrosyl-DNA phosphodiesterase 1 |
Potency |
14963.1 |
nM |
None |
Homo sapiens |
Solute carrier organic anion transporter family member 1B3 |
Inhibition |
99.56 |
% |
10.1124/mol.112.084152 |
Homo sapiens |
DNA-(apurinic or apyrimidinic site) lyase |
Potency |
7079.5 |
nM |
None |
Homo sapiens |
DNA-(apurinic or apyrimidinic site) lyase |
Potency |
44668.4 |
nM |
None |
Homo sapiens |
Protein-tyrosine phosphatase 1B |
Inhibition |
7.7 |
% |
10.1016/j.bmcl.2015.03.014 |
None |
NON-PROTEIN TARGET |
IC50 |
100000.0 |
nM |
10.1039/C5MD00581G |
None |
NON-PROTEIN TARGET |
IC50 |
100000.0 |
nM |
10.1039/C5MD00581G |
Homo sapiens |
HeLa |
IC50 |
100000.0 |
nM |
10.1039/C5MD00581G |
Homo sapiens |
A549 |
IC50 |
100000.0 |
nM |
10.1039/C5MD00581G |
Homo sapiens |
MCF7 |
IC50 |
100000.0 |
nM |
10.1039/C5MD00581G |
Homo sapiens |
HL-60 |
IC50 |
10000.0 |
nM |
10.1021/acs.jnatprod.6b01146 |
Homo sapiens |
PC-3 |
IC50 |
10000.0 |
nM |
10.1021/acs.jnatprod.6b01146 |
Homo sapiens |
SGC-7901 |
IC50 |
10000.0 |
nM |
10.1021/acs.jnatprod.6b01146 |
Staphylococcus aureus |
Staphylococcus aureus |
MIC |
1000.0 |
ug.mL-1 |
10.1016/j.ejmech.2018.10.012 |
Bos taurus |
Calf thymus DNA |
Activity |
nan |
None |
10.1016/j.bmcl.2016.08.047 |
Bos taurus |
Calf thymus DNA |
Tm |
65.0 |
degrees C |
10.1016/j.bmcl.2016.08.047 |
Bos taurus |
Calf thymus DNA |
Activity |
nan |
None |
10.1016/j.bmcl.2016.08.047 |
Bos taurus |
Calf thymus DNA |
Delta Tm |
4.0 |
degrees C |
10.1016/j.bmcl.2016.08.047 |
Bos taurus |
Calf thymus DNA |
Activity |
nan |
None |
10.1016/j.bmcl.2016.08.047 |
Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
Inhibition |
0.5 |
% |
10.6019/CHEMBL4495565 |